Tumentia Research
Dementia research, diagnosis, and treatment access.
About Tumentia Research
Tumentia Research, also operating as the Dementia Studies Foundation, is a 501(c)(3) non-profit organization dedicated to addressing Alzheimer's and Dementia. The foundation's core mission is to remove barriers to dementia research, diagnosis, and treatment for all communities. They aim to build trust, empower individuals, and promote inclusive, evidence-based approaches to brain health.
Operating from Athens, Texas, the organization works towards a future focused on finding a cure for Alzheimer's and Dementia. It provides a platform for solutions targeted at pharmaceutical companies, medical device manufacturers, and healthcare providers. Their services appear to encompass regulatory submissions, data management, clinical trial management, and medical writing, suggesting a role as a contract research organization or a similar entity supporting clinical research.
The broader context of their work is the growing public health concern of dementia, which is the seventh leading cause of death globally and a major source of disability among older adults. Research in this field, which Tumentia supports, involves investigating lifestyle interventions, genetic factors, and disease pathways to develop biomarkers for early detection and new treatments. The ultimate goal is to translate scientific knowledge into effective prevention and treatment strategies for diseases like Alzheimer's, which is the most common form of dementia.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2014
- Headquarters
- Casper, United States
- Open positions
- None listed
- Dealroom signal
- 19.0/100
- Industry
- Health
- Sub-industry
- Pharmaceutical
- Sector
- Biotech & Life Sciences, Biotechnology, Oncology, Verified Unicorns and $1B Exits, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Oct 2017 | $1.2B | $1.2B | Excellence Health | — |
| SERIES AOther financing | Jan 2015 | $60M | $240M | Undisclosed | — |
Growth signals
Latest recorded traffic for Tumentia Research is 0 monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Tumentia Research in the Casper ecosystem
The Tumentia Research office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors1 additional known investor
Excellence Health
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Tumentia Research on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Tumentia Research’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









